Creative Solutions to Launching & Funding Early Stage Bioscience Companies in the New Economy
by Boltonhillconsulting on Apr 04, 2009
- 1,161 views
Speakers who will present at this TCM/Bio Breakfast event organized by Bolton Hill Consulting and co-hosted by GBC & GBTC and sponsored by Arcion Therapeutics, Martek, VWR, and the University of ...
Speakers who will present at this TCM/Bio Breakfast event organized by Bolton Hill Consulting and co-hosted by GBC & GBTC and sponsored by Arcion Therapeutics, Martek, VWR, and the University of Maryland BioPark.
UMB BioPark Life Sciences Conference Center First Floor 801 West Baltimore St Baltimore, MD 21201
4/16/09 7:30-10:30 am
In today’s economic environment, more so than at any other time, it is imperative for emerging and early-stage companies to be able to identify and access both traditional and non-traditional sources of capital. What are some of the creative funding strategies that Maryland-based entrepreneurs have successfully used to keep their products and projects moving through development?
Hear from our panel of funding specialists representing foundations, angel investment groups, venture capital firms, and the State government as they describe their programs and the resources available to help fledgling businesses. In addition, a group of well-respected local bioscience entrepreneurs will share their first-hand experiences in overcoming the challenges posed by today’s financial crisis.
Join us for an informative and interactive discussion. Our speakers include:
Paul Silber, Ph.D. (moderator)
Director, Evergreen Capital
Former CEO, InVitro Technologies
Delegate Dan Morhaim, M.D.
Deputy Majority Leader
Maryland House of Delegates
Margaret A. Anderson
Chief Operating Officer
Youseph Yazdi, Ph.D.
Corporate Director, Corporate Office of Science and Technology
Johnson and Johnson
Registration link: https://techcouncilmd.com/events/register.php
- Total Views
- Views on SlideShare
- Embed Views